Compare VIR & ARLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VIR | ARLO |
|---|---|---|
| Founded | 2016 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 2019 | 2018 |
| Metric | VIR | ARLO |
|---|---|---|
| Price | $9.36 | $15.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | $19.43 | ★ $24.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 17.49 | ★ 145.16 |
| EPS | N/A | ★ 0.13 |
| Revenue | ★ $68,556,000.00 | N/A |
| Revenue This Year | $270.22 | $9.29 |
| Revenue Next Year | N/A | $8.82 |
| P/E Ratio | ★ N/A | $106.79 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.16 | $11.05 |
| 52 Week High | $11.66 | $19.94 |
| Indicator | VIR | ARLO |
|---|---|---|
| Relative Strength Index (RSI) | 43.07 | 62.59 |
| Support Level | $8.47 | $13.14 |
| Resistance Level | $10.29 | $16.37 |
| Average True Range (ATR) | 0.47 | 0.62 |
| MACD | -0.16 | 0.07 |
| Stochastic Oscillator | 8.48 | 51.13 |
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.
Arlo Technologies Inc is engaged in the provision of security and video monitoring solutions for homes and businesses. It combines a cloud infrastructure and mobile app with various smart connected devices to provide users with visibility, insight, and a means to help protect and connect in real-time with the people and things from any location with a Wi-Fi or a cellular connection. The company offers subscription services such as Arlo Secure, Arlo Total Security, and Arlo Safe, and several categories of smart security devices, including smart Wi-Fi and LTE-enabled cameras, video doorbells, floodlight cameras, and home security systems. Geographically, the company generates a majority of its revenue from the United States, followed by Spain, Sweden, and other countries.